Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. (CELZ) filed a Form 8-K on December 26, 2025, reporting the results of a Special Meeting of Stockholders held on the same date. The company is incorporated in Nevada and trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The primary material event reported is the approval by stockholders of a proposal to exercise in full warrants to purchase an aggregate of 2,790,340 shares of the Company's common stock. These warrants were originally issued on October 29, 2025.
Outlook and Voting Results
At the Special Meeting, a quorum was established with 1,037,465 shares present, representing 36.4% of outstanding common stock. The proposal to exercise the warrants was approved with the following vote breakdown:
- For: 618,178 votes
- Against: 183,985 votes
- Abstain: 235,381 votes (Note: Includes 220,500 votes cast "For" by warrant holders, which were treated as "Abstain" per Nasdaq Listing Rules)
The filing does not provide specific management commentary on future outlook, risks, or contingencies beyond the procedural details of the warrant exercise.
Investor Verification Checklist
- Verify the definitive proxy statement filed on November 13, 2025, for detailed terms of the warrant exercise.
- Confirm the impact of the 2,790,340 new shares on total outstanding share count and potential dilution.
- Review the company's subsequent filings for updated financial statements reflecting the capital raised from the warrant exercise.